Total Payments
$16,021
2024 Payments
$1,983
Companies
56
Transactions
1,050
Medicare Patients
6,720
Medicare Billing
$606,106
Payment Breakdown by Category
Food & Beverage$15,896 (99.2%)
Education$125.74 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $15,896 | 1,046 | 99.2% |
| Education | $125.74 | 4 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $2,431 | 237 | $0 (2024) |
| ABBVIE INC. | $1,760 | 85 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $1,639 | 83 | $0 (2024) |
| Lilly USA, LLC | $1,176 | 81 | $0 (2024) |
| Amgen Inc. | $853.87 | 55 | $0 (2024) |
| PFIZER INC. | $788.71 | 54 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $748.70 | 50 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $657.89 | 42 | $0 (2024) |
| Merck Sharp & Dohme LLC | $542.50 | 31 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $518.13 | 35 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,983 | 110 | Novo Nordisk Inc ($410.31) |
| 2023 | $2,191 | 135 | AbbVie Inc. ($564.52) |
| 2022 | $2,258 | 139 | ABBVIE INC. ($486.25) |
| 2021 | $2,330 | 142 | AbbVie Inc. ($341.50) |
| 2020 | $1,908 | 128 | AstraZeneca Pharmaceuticals LP ($304.71) |
| 2019 | $1,466 | 105 | Novo Nordisk Inc ($274.83) |
| 2018 | $1,905 | 132 | Novo Nordisk Inc ($272.29) |
| 2017 | $1,982 | 159 | Boehringer Ingelheim Pharmaceuticals, Inc. ($267.00) |
All Payment Transactions
1,050 individual payment records from CMS Open Payments — Page 1 of 42
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: PAIN | ||||||
| 12/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.17 | General |
| Category: Diabetes | ||||||
| 12/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.47 | General |
| Category: Diabetes | ||||||
| 12/13/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $8.72 | General |
| Category: Diabetes | ||||||
| 12/04/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $25.19 | General |
| Category: Biological | ||||||
| 12/03/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Oncology | ||||||
| 11/20/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.18 | General |
| Category: Endocrinology | ||||||
| 11/13/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $21.07 | General |
| Category: Cardio-renal | ||||||
| 11/12/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $54.28 | General |
| Category: Hematology | ||||||
| 11/08/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $14.64 | General |
| Category: Diabetes Care | ||||||
| 11/07/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.45 | General |
| Category: NEUROSCIENCE | ||||||
| 11/04/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.33 | General |
| Category: Diabetes | ||||||
| 11/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.67 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $21.92 | General |
| Category: NEUROSCIENCE | ||||||
| 10/17/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: PSYCHIATRY | ||||||
| 10/16/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.10 | General |
| Category: NEUROSCIENCE | ||||||
| 10/16/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: GASTROENTEROLOGY | ||||||
| 10/13/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $20.59 | General |
| Category: Diabetes | ||||||
| 10/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $15.06 | General |
| Category: Respiratory | ||||||
| 10/09/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $29.57 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 10/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/02/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $20.24 | General |
| Category: VACCINE | ||||||
| 10/01/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $25.58 | General |
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $18.89 | General |
| Category: Diabetes | ||||||
| 09/27/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,549 | 2,907 | $266,008 | $145,344 |
| 2022 | 23 | 1,663 | 3,278 | $305,767 | $169,752 |
| 2021 | 28 | 1,715 | 3,204 | $284,966 | $151,047 |
| 2020 | 31 | 1,793 | 3,329 | $304,221 | $139,963 |
Total Patients
6,720
Total Services
12,718
Medicare Billing
$606,106
Procedure Codes
101
All Medicare Procedures & Services
101 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 145 | 1,016 | $71,120 | $43,024 | 60.5% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 356 | 356 | $71,200 | $42,798 | 60.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 147 | 245 | $28,175 | $13,158 | 46.7% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 134 | 145 | $23,925 | $9,680 | 40.5% |
| 99307 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 10 minutes | Facility | 2023 | 69 | 190 | $11,400 | $5,529 | 48.5% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 27 | 126 | $10,080 | $4,809 | 47.7% |
| 99305 | Initial nursing facility care with moderate level of medical decision making, per day, if using time, at least 35 minutes | Facility | 2023 | 40 | 43 | $7,310 | $4,354 | 59.6% |
| 99308 | Subsequent nursing facility care with straightforward level of medical decision making, per day, if using time, at least 15 minutes | Facility | 2023 | 55 | 81 | $7,290 | $4,227 | 58.0% |
| 99439 | Chronic care management services for two or more chronic conditions, additional 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 45 | 114 | $5,450 | $3,685 | 67.6% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 23 | 23 | $5,750 | $3,416 | 59.4% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 191 | 191 | $4,202 | $3,186 | 75.8% |
| 99304 | Initial nursing facility care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 24 | 26 | $3,120 | $1,590 | 51.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 108 | 151 | $4,530 | $1,438 | 31.7% |
| 99348 | Residence visit for established patient with low level of medical decision making, per day, if using time, at least 30 minutes | Office | 2023 | 16 | 26 | $3,120 | $1,331 | 42.6% |
| 99309 | Subsequent nursing facility care with moderate level of medical decision making, per day, if using time, at least 30 minutes | Facility | 2023 | 21 | 26 | $3,120 | $1,148 | 36.8% |
| G0442 | Annual alcohol misuse screening, 5 to 15 minutes | Office | 2023 | 51 | 51 | $1,173 | $850.68 | 72.5% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 11 | 11 | $3,685 | $632.09 | 17.2% |
| 82044 | Urine microalbumin (protein) analysis | Office | 2023 | 73 | 73 | $1,241 | $446.03 | 35.9% |
| 81002 | Urinalysis, manual test | Office | 2023 | 13 | 13 | $117.00 | $44.33 | 37.9% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 159 | 1,232 | $84,845 | $52,092 | 61.4% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 387 | 387 | $77,400 | $47,444 | 61.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 198 | 247 | $40,755 | $18,152 | 44.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 171 | 260 | $29,900 | $12,953 | 43.3% |
| 90677 | Pneumococcal conjugate vaccine, 20 valent (pcv20), for intramuscular use | Office | 2022 | 27 | 27 | $8,775 | $7,471 | 85.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 31 | 141 | $11,280 | $5,394 | 47.8% |
About Dr. Roy Bowden, DO
Dr. Roy Bowden, DO is a Internal Medicine healthcare provider based in Charleston, West Virginia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1174594642.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Roy Bowden, DO has received a total of $16,021 in payments from pharmaceutical and medical device companies, with $1,983 received in 2024. These payments were reported across 1,050 transactions from 56 companies. The most common payment nature is "Food and Beverage" ($15,896).
As a Medicare-enrolled provider, Bowden has provided services to 6,720 Medicare beneficiaries, totaling 12,718 services with total Medicare billing of $606,106. Data is available for 4 years (2020–2023), covering 101 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Charleston, WV
- Active Since 01/31/2006
- Last Updated 09/04/2024
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1174594642
Products in Payments
- Ozempic (Drug) $1,177
- UBRELVY (Drug) $928.07
- FARXIGA (Drug) $730.65
- ENTRESTO (Drug) $600.05
- QULIPTA (Drug) $533.52
- JARDIANCE (Drug) $471.76
- TRULICITY (Drug) $436.06
- XIFAXAN (Drug) $375.34
- BREZTRI (Drug) $347.75
- Tresiba (Drug) $337.96
- Aimovig (Biological) $302.49
- Rybelsus (Drug) $297.32
- Kerendia (Drug) $279.12
- NURTEC ODT (Drug) $269.05
- Vascepa (Drug) $258.08
- VRAYLAR (Drug) $255.17
- Prolia (Biological) $253.88
- BELSOMRA (Drug) $250.38
- XARELTO (Drug) $247.50
- MOUNJARO (Drug) $239.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Charleston
William Chapman, Do, DO
Internal Medicine — Payments: $1.3M
Internal Medicine $1.3M
Dr. Ryan Tedford, M.d, M.D
Internal Medicine — Payments: $432,170
Internal Medicine $432,170
Harold Szerlip, Md, MD
Internal Medicine — Payments: $284,278
Internal Medicine $284,278
Dr. Nathan Shores, M.d, M.D
Internal Medicine — Payments: $262,570
Internal Medicine $262,570
Hamza Hashmi, M.d, M.D
Internal Medicine — Payments: $234,146
Internal Medicine $234,146
Dr. Anne Kroman, D.o., Phd, D.O., PHD
Internal Medicine — Payments: $202,518
Internal Medicine $202,518